Although more investigation is needed, the iTregs with IL-10-mediated suppressive action represent promising targets for future allergy therapies, and potential efficacy biomarker for novel types of allergen-specific immunotherapy and cell-based therapies. The gene discussed is IL10; the disease is Allergy.